233 related articles for article (PubMed ID: 3882737)
21. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
Lamberts SW; de Quijada M; Klijn JG
J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
Schettini G; Lombardi G; Merola B; Miletto P; Fariello C; Cirillo S; Fusco R; Lancranjan I
J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
[TBL] [Abstract][Full Text] [Related]
23. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
[TBL] [Abstract][Full Text] [Related]
24. Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptine.
Chakera TM; Khangure MS; Pullen P
Clin Radiol; 1985 May; 36(3):223-6. PubMed ID: 4064503
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
26. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
[TBL] [Abstract][Full Text] [Related]
27. Reduction in size of a pituitary tumor by bromocriptine therapy.
McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
[No Abstract] [Full Text] [Related]
28. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
29. Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
Robbins RJ; Kern PA; Thompson TL
Am J Med; 1984 May; 76(5):921-3. PubMed ID: 6720732
[TBL] [Abstract][Full Text] [Related]
30. Long term treatment with CV 205-502 in patients with prolactin-secreting pituitary macroadenomas.
Serri O; Beauregard H; Lesage J; Pedneault L; Comtois R; Jilwan N; Somma M; Vachon L; Brownell J
J Clin Endocrinol Metab; 1990 Sep; 71(3):682-7. PubMed ID: 2394774
[TBL] [Abstract][Full Text] [Related]
31. Long-acting bromocriptine for the acute treatment of large macroprolactinomas.
Zarate A; Moran C; Miranda R; Loyo M; Medina M; Fonseca ME
J Endocrinol Invest; 1987 Jun; 10(3):233-6. PubMed ID: 3624799
[TBL] [Abstract][Full Text] [Related]
32. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
[TBL] [Abstract][Full Text] [Related]
33. [Radiological control of prolactin adenomas treated with bromocriptine].
Metzger J; Gardeur D; Pehuet M; Houlbert D
Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
[No Abstract] [Full Text] [Related]
34. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
[TBL] [Abstract][Full Text] [Related]
35. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Boulanger CM; Mashchak CA; Chang RJ
Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
[TBL] [Abstract][Full Text] [Related]
36. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
[TBL] [Abstract][Full Text] [Related]
37. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G
Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607
[TBL] [Abstract][Full Text] [Related]
38. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
[TBL] [Abstract][Full Text] [Related]
39. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
[TBL] [Abstract][Full Text] [Related]
40. Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.
van 't Verlaat JW; Croughs RJ; Hendriks MJ; Bosma NJ; Nortier JW; Thijssen JH
Acta Endocrinol (Copenh); 1986 Aug; 112(4):487-93. PubMed ID: 3751462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
